1. Review and apply national guideline treatment strategies for the following gastrointestinal (GI) disorders: gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), ulcerative colitis, Crohn's disease, viral hepatitis, chronic liver disease, upper GI bleeding, constipation, diarrhea, irritable bowel syndrome (IBS), nausea, vomiting, pancreatitis, prevention of stress related mucosal disease (SRMD). stress related mucosal disease (SRMD).
2. Recommend appropriate pharmacologic and nonpharmacologic interventions for the treatment of GERD.
3. Differentiate between clinical signs, symptoms, risk factors, and treatment of both Helicobacter pylori and nonsteroidal anti-inflammatory drug (NSAID)-associated PUD.
4. Discuss the role of pharmacologic intervention in the treatment of nonvariceal upper GI bleeding.
5. Review the clinical differences in signs, symptoms, and treatment of Crohn's disease and ulcerative colitis. colitis.
6. Identify the common manifestations of chronic liver disease and their treatment.
7. Review the treatment of both acute and chronic viral hepatitis.
8. Recognize pertinent information for educating patients and prescribers regarding the appropriate use of pharmacologic agents for various GI disorders.
9. Recommend appropriate pharmacologic and nonpharmacologic interventions for diarrhea and constipation.
10. Review recommendations for the treatment and prevention of nausea and vomiting 11. Discuss the clinical and treatment differences 11. Discuss the clinical and treatment differences between acute and chronic pancreatitis. 
